3 Trinity Biotech plc Analyst Ratings, Earnings, Dividends and Insider Trades | $TRIB | NASDAQ:TRIB | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Trinity Biotech plc Company Profile (NASDAQ:TRIB) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Trinity Biotech plc (NASDAQ:TRIB) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 1 Sell Rating(s), 1 Buy Rating(s)Consensus Rating:Hold (Score: 2.00)Consensus Price Target: $26.75 3.36% downside) Analysts' Ratings History for Trinity Biotech plc (NASDAQ:TRIB) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/5/2014Roth CapitalBoost Price Target$22.00 -> $28.00View 2/18/2014ZacksDowngradeNeutral -> Underperform$25.50View 11/19/2013SidotiInitiated CoverageBuyView 10/30/2013ZacksDowngradeOutperform -> Neutral$26.60View 10/1/2013ZacksUpgradeNeutral -> Outperform$23.10View 3/7/2013Roth CapitalBoost Price Target$15.50 -> $17.50View 3/5/2013Craig HallumInitiated CoverageBuyView 1/22/2013Roth CapitalDowngradeBuy -> Neutral$15.50View 6/20/2012B. RileyInitiated CoverageBuyView 6/12/2012SidotiInitiated CoverageBuyView (Data available from 3/12/2012 forward) Earnings History for Trinity Biotech plc (NASDAQ:TRIB)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare3/4/2014Q4$0.21$0.20ViewN/AView 10/17/2013Q313$0.21$0.21$24.68 million$24.10 millionViewN/AView 7/30/2013Q2 2013$0.20$0.21$22.03 million$21.30 millionViewN/AView 3/5/2013Q4 2012$0.21$0.20$21.84 million$20.80 millionViewN/AView (Data available from 1/1/2011 forward) Dividend History for Trinity Biotech plc (NASDAQ:TRIB)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Trinity Biotech plc (NASDAQ:TRIB)No insider trades for this company have been tracked by Analyst Ratings Network About Trinity Biotech plc Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a significant provider of raw materials to the life sciences industry. Trinity Biotech markets its portfolio of over 500 products to customers in 75 countries worldwide. Trinity Biotech markets its products in the United States and the rest of the world through a combination of direct selling and a network of national and international distributors. It has established direct sales forces in the United States, Germany, France and the United Kingdom. In May 2010, the Company disposed of its coagulation business to the Stago Group. Headlines: (2/19) Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2013 Financial Results (3/4) Trinity Biotech Announces Results for Q4 and Fiscal Year 2013 (3/3) Pre-Market Earnings Report for March 4, 2014 : BNS, AZO, HTH, TSL, SSP, BRLI, TRIB, JRN, GTIV, MCGC, RIGL, RSH Industry, Sector and Symbol: Sector: Healthcare Industry: N/A Sub-Industry: N/A Exchange: NASDAQ Symbol: TRIB CUSIP: Key Metrics: Previous Close: $27.7350 Day Moving Average: $26.3423200 Day Moving Average: $24.0799 P/E Ratio: N/AP/E Growth: 1.54Market Cap: $N/ACurrent Quarter EPS Consensus Estimate: $0.90 EPS Additional Links: View TRIB on Google FinanceView TRIB on Yahoo FinanceView TRIB's Company Profile on ReutersSearch for Trinity Biotech plc on Google Trinity Biotech plc (NASDAQ:TRIB) Chart for Wednesday, March, 12, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.